22 September 1986
COMMERCIAL ITEM DESCRIPTION
CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Cetylpyridinium Chloride and Benzocaine Lozenges.
Each Lozenge shall contain 1.5 mg of Cetylpyridinium Chloride and 10 mg of Benzocaine in a suitable hard candy base.
Shall contain not less than 90.0 percent and not more than 120.0 percent of the required amount of Cetylpyridinium Chloride when assayed by a suitable, accurate and reproducible method.
Shall contain not less than 90.0 percent and not more than 130.0 percent of the required amount of free and combined Benzocaine when tested by a suitable, accurate and reproducible method.
Shall conform to the weight variation requirement for Cetylpyridinium Chloride Lozenges, USP.
Workmanship. The lozenges shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Package (PG). Nine lozenges shall be supplied in blister or strip packaging of such compatibility that neither the contents nor the container are altered in any way by each other. One package containing 36 blister or strip package (324 lozenges), as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business